Learning from COVID-19 to Tackle Antibiotic Resistance

The unchecked growth of drug-resistant infections is a silent pandemic with long-term implications for global health. As the world reels from the impact of COVID-19, a new GARDP report explores how to apply the lessons we are learning to the fight against drug resistance. The report examines five early lessons of the COVID-19 pandemic and how these lessons can be applied to a successful long-term response to antibiotic resistance.

Financial Report 2019

As the first financial year ends on 31 December 2019, this financial report represents the combined financial statement and activities of GARDP carried out in DNDi and GARDP for the 12 months period ending 31 December 2019.

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.